Protection against experimental infection with group B streptococcus by immunization with a bivalent protein vaccine

Author： Larsson C. Stalhammar-Carlemalm M. Lindahl G.

Publisher： Elsevier

ISSN： 0264-410X

Source： Vaccine, Vol.17, Iss.5, 1999-02, pp. : 454-458

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Protection against influenza B virus infection by immunization with DNA vaccines

By Chen Z. Kadowaki S.-e. Hagiwara Y. Yoshikawa T. Sata T. Kurata T. Tamura S.-i.

Vaccine, Vol. 19, Iss. 11, 2001-12 ,pp. : 1446-1455

Elsevier

Access to resources Recommend Favorite

An experimental bivalent peptide vaccine against schistosomiasis and fascioliasis

By Vilar M.M. Barrientos F. Almeida M. Thaumaturgo N. Simpson A. Garratt R. Tendler M.

Vaccine, Vol. 22, Iss. 1, 2003-12 ,pp. : 137-144

Elsevier

Access to resources Recommend Favorite

Immunization of mice with recombinant L7/L12 ribosomal protein confers protection against Brucella abortus infection

By Oliveira S.C. Splitter G.A.

Vaccine, Vol. 14, Iss. 10, 1996-07 ,pp. : 959-962

Elsevier

Access to resources Recommend Favorite

Protection of mice from group A streptococcal infection by intranasal immunisation with a peptide vaccine that contains a conserved M protein B cell epitope and lacks a T cell autoepitope

By Olive C. Clair T. Yarwood P. Good M.F.

Vaccine, Vol. 20, Iss. 21, 2002-06 ,pp. : 2816-2825

Elsevier

Access to resources Recommend Favorite

Expression of cereolysine AB genes in Bacillus anthracis vaccine strain ensures protection against experimental hemolytic anthrax infection

By Pomerantsev A.P. Staritsin N.A. Mockov Y.V. Marinin L.I.

Vaccine, Vol. 15, Iss. 17, 1997-12 ,pp. : 1846-1850

Elsevier

Access to resources Recommend Favorite